| Name | Title | Contact Details |
|---|
Leading Research into Solving one of the World`s Largest Drivers of Disease: Inflammation
Helping protect life through fundamental breakthroughs in vaccine adjuvant design and manufacturing.
IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer. Our proprietary oncolytic virus platform is based on technology developed by scientific founder Clodagh O`Shea, Ph.D., of the Salk Institute. It is designed to address key limitations of first- and second-generation oncolytic viruses.
Fluke Biomedical Corp. is a Everett, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nano-C is a Westwood, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.